• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

假设病例替换可用于量化试验结果的稳健性。

Hypothetical case replacement can be used to quantify the robustness of trial results.

机构信息

Measurement and Quantitative Methods, Education; Agriculture and Natural Resources, Michigan State University, East Lansing, MI.

Center for Spatial Data Science, University of Chicago, Chicago IL.

出版信息

J Clin Epidemiol. 2021 Jun;134:150-159. doi: 10.1016/j.jclinepi.2021.01.025. Epub 2021 Mar 15.

DOI:10.1016/j.jclinepi.2021.01.025
PMID:33737070
Abstract

OBJECTIVES

We apply a general case replacement framework for quantifying the robustness of causal inferences to characterize the uncertainty of findings from clinical trials.

STUDY DESIGN AND SETTING

We express the robustness of inferences as the amount of data that must be replaced to change the conclusion and relate this to the fragility of trial results used for dichotomous outcomes. We illustrate our approach in the context of an RCT of hydroxychloroquine on pneumonia in COVID-19 patients and a cumulative meta-analysis of the effect of antihypertensive treatments on stroke.

RESULTS

We developed the Robustness of an Inference to Replacement (RIR), which quantifies how many treatment cases with positive outcomes would have to be replaced with hypothetical patients who did not receive a treatment to change an inference. The RIR addresses known limitations of the Fragility Index by accounting for the observed rates of outcomes. It can be used for varying thresholds for inference, including clinical importance.

CONCLUSION

Because the RIR expresses uncertainty in terms of patient experiences, it is more relatable to stakeholders than P-values alone. It helps identify when results are statistically significant, but conclusions are not robust, while considering the rareness of events in the underlying data.

摘要

目的

我们应用一般病例替换框架来量化因果推断的稳健性,以描述临床试验结果的不确定性。

研究设计和设置

我们将推断的稳健性表示为必须替换的数据量,以改变结论,并将其与用于二分类结果的试验结果的脆弱性联系起来。我们在羟氯喹治疗 COVID-19 肺炎的 RCT 和降压治疗对卒中影响的累积荟萃分析的背景下说明了我们的方法。

结果

我们开发了对替换的推断稳健性(RIR),它量化了需要用假设的未接受治疗的患者替换多少阳性结果的治疗病例才能改变推断。RIR 通过考虑观察到的结局发生率来解决脆弱性指数的已知局限性。它可用于不同的推断阈值,包括临床重要性。

结论

因为 RIR 用患者体验来表示不确定性,所以它比 P 值更能与利益相关者相关。它有助于确定结果具有统计学意义,但结论不稳健的情况,同时考虑到基础数据中事件的罕见性。

相似文献

1
Hypothetical case replacement can be used to quantify the robustness of trial results.假设病例替换可用于量化试验结果的稳健性。
J Clin Epidemiol. 2021 Jun;134:150-159. doi: 10.1016/j.jclinepi.2021.01.025. Epub 2021 Mar 15.
2
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
3
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.一项评估法匹拉韦和羟氯喹联合治疗中重度 COVID-19 住院成人的疗效和安全性的随机对照研究:研究方案的结构化总结。
Trials. 2020 Oct 31;21(1):904. doi: 10.1186/s13063-020-04825-x.
4
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).老年人伴有症状的严重急性呼吸综合征冠状病毒 2 型感染(COVID-19)的家庭治疗:一项多臂多阶段(MAMS)随机试验研究方案的结构化总结,旨在评估几种实验性治疗方法在降低 65 岁及以上门诊患者住院或死亡风险方面的疗效和耐受性(COVERAGE 试验)。
Trials. 2020 Oct 13;21(1):846. doi: 10.1186/s13063-020-04619-1.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.干扰素 β1a 对比干扰素 β1b 和常规治疗方案治疗中重度 COVID-19 成人患者的效果:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):473. doi: 10.1186/s13063-020-04382-3.
7
Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.羟氯喹与羟氯喹+硝唑尼特治疗有不良预后风险因素的 COVID-19 患者:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 8;21(1):504. doi: 10.1186/s13063-020-04448-2.
8
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.抗病毒联合治疗在新冠病毒感染有症状患者中的安全性和有效性 - 一项随机对照试验(SEV-COVID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 20;21(1):866. doi: 10.1186/s13063-020-04774-5.
9
Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.羟氯喹治疗初级保健环境中成人 COVID-19 感染患者(LIBERTY):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):44. doi: 10.1186/s13063-020-04989-6.
10
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.

引用本文的文献

1
On clinical trial fragility due to patients lost to follow up.由于患者失访导致的临床试验脆弱性。
BMC Med Res Methodol. 2021 Nov 20;21(1):254. doi: 10.1186/s12874-021-01446-z.
2
Social-spatial network structures and community ties of egocentric sex and confidant networks: A Chicago case study.自我中心的性网络和知己网络的社会空间网络结构和社区联系:芝加哥案例研究。
Soc Sci Med. 2021 Dec;291:114462. doi: 10.1016/j.socscimed.2021.114462. Epub 2021 Oct 13.